Ludwig Appoints Dr. Kyle Ambert Ph.D. to Scientific Advisory Board
By:
Ludwig Enterprises Inc. via
AccessWire
July 21, 2022 at 08:45 AM EDT
SPARKS, NV / ACCESSWIRE / July 21, 2022 / Ludwig (OTC PINK:LUDG) is pleased to announce that Dr. Marvin S. Hausman MD, Chairman of Ludwig's Scientific Advisory Board (SAB) has appointed Dr. Kyle H. Ambert, PhD to its SAB, effective immediately. Dr.Ambert has also agreed to become a consultant to Ludwig and its subsidiary mRNA for Life, Inc. and will assist the Company in designing clinical studies and analyzing their results. Dr. Ambert is currently Director of Data Science at Nike, Inc., and has extensive experience in data analytics, machine learning, artificial intelligence, and applied analytics. His previous experience includes postings with the National Library of Medicine and Intel Corp. Dr. Ambert holds a PhD in Biomedical Informatics from Oregon Health & Science University. Dr. Marvin S. Hausman MD, Chairman of the Ludwig SAB commented, "I am extremely pleased to welcome Dr. Ambert to our team. Dr. Ambert's knowledge of applied machine learning and deep learning represents a major addition to the Company as we develop proprietary genetic biomarkers that may have the potential to diagnose early onset of cancer and predict response to various anticancer treatments. "I am pleased to be asked to join Ludwig's SAB and look forward to assisting in the research, development and launch of the Company's cancer-genomic and inflammatory messenger RNA program," said Dr. Ambert. SAFE HARBOR Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements are not a guarantee of future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately priced, retain, and complete projects and changes in products and competition. CONTACT: Ludwig Enterprises, or SOURCE: Ludwig Enterprises, Inc. View source version on accesswire.com: https://www.accesswire.com/709295/Ludwig-Appoints-Dr-Kyle-Ambert-PhD-to-Scientific-Advisory-Board More NewsView More
Wall Street Sees a Winner in Take-Two Stock. Should You? ↗
Today 7:29 EST
Via MarketBeat
Tickers
TTWO
Datavault AI Just Raised Guidance by 400%—Are You Paying Attention? ↗
November 20, 2025
Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One ↗
November 20, 2025
Via MarketBeat
Tickers
LAC
Joby and Archer Forge a New Strategic Chapter in the UAE ↗
November 20, 2025
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|